‹ All stocks
Drugs Made In America Acquisition II Corp. Unit
DMIIU · NASDAQ · Financial Services
$10.20
— $10.20 (0.00%)
Day range
$10.20 – $10.25
Year range
$9.95 – $10.80
Open
$10.20
Previous close
—
Market cap
$709.35M
Volume (24h)
$622
Volume (52w)
$6.34K
Performance
7D
— 0.00%
1M
▼ -0.49%
3M
▲ 0.39%
6M
▲ 1.59%
1Y
▲ 2.51%
YTD
▲ 2.00%
3Y
▲ 2.10%
5Y
▲ 2.10%
All-time
▲ 2.10%
Key statistics
P/E ratio
—
EPS (TTM)
—
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
69.5M
About Drugs Made In America Acquisition II Corp. Unit
DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands. Its core objective is to identify and complete a merger or acquisition with an existing business. The company specifically aims to acquire targets within the pharmaceutical and drug industries, driven by the goal of reducing the United States' reliance on international drug manufacturing. Each investment unit comprises one common stock share and an associated right, which entitles the holder to an additional one-tenth of a share once a suitable business combination is successfully finalized.
Visit websiteCountry: United States of America
More in Financial Services
BRK-B Berkshire Hathaway |
$500.52 | 0.08% |
JPM JPMorgan Chase & Co. |
$330.92 | -0.92% |
V Visa |
$359.82 | -0.11% |
MA Mastercard Incorporated |
$551.37 | 0.01% |
BAC Bank of America |
$53.63 | -0.49% |